"Yttrium Radioisotopes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unstable isotopes of yttrium that decay or disintegrate emitting radiation. Y atoms with atomic weights 82-88 and 90-96 are radioactive yttrium isotopes.
| Descriptor ID |
D015021
|
| MeSH Number(s) |
D01.268.558.975.500.800 D01.268.956.890.500.800 D01.496.749.960 D01.496.943.800 D01.552.550.975.500.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Yttrium Radioisotopes".
Below are MeSH descriptors whose meaning is more specific than "Yttrium Radioisotopes".
This graph shows the total number of publications written about "Yttrium Radioisotopes" by people in this website by year, and whether "Yttrium Radioisotopes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Yttrium Radioisotopes" by people in Profiles.
-
90Y Radioembolization: Telemedicine During COVID-19 Outbreak, Opportunity for Prime Time. J Nucl Med. 2020 06; 61(6):780.
-
Neuroendocrine Liver Metastases. Cardiovasc Intervent Radiol. 2019 07; 42(7):1053-1054.
-
Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres. J Vasc Interv Radiol. 2019 03; 30(3):314-319.
-
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018 Jun 08; 18(1):646.
-
Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization. Cardiovasc Intervent Radiol. 2018 Sep; 41(9):1373-1383.
-
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib. Future Oncol. 2018 Apr; 14(8):727-735.
-
The ten commandments of hepatic radioembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2017 Sep; 21(18):4014-4021.